Enquirer Consulting Group
Prepared for Exocel Bio

The LinkedIn MVP.

One channel. The lowest bar that proves it. Then we scale what works.
Proposal call with Alex Contreras, Chief Commercial Officer and Co-Founder. September 2026. Dan Reeves and Paul Smaldone.
BUILD RUN OWN
Enquirer Consulting Group, September 2026. Confidential, prepared for Exocel Bio.
Enquirer AI is the outbound engine of Enquirer Consulting Group.
What you asked for last Thursday

Five things you asked for. And one you did not.

ONE

The universe

Every LinkedIn target in the segments you named. The three roles you named, doctors, nurse practitioners and office managers, plus the owner or medical director above them. Sized before we ask you for a thing.

TWO

The profiles

Which LinkedIn identities we run from. Yours, a team member's, or accounts we provide in real names as Exocel Bio representatives.

THREE

The sequence

What gets sent, in what order, written for one person at a time from their profile and their practice.

FOUR

How it activates

Week by week through the first 30 days. Who does what, and where a reply goes the moment it lands.

FIVE

What counts as a conversation

You did not ask for this one, Paul did. It goes in anyway, because the target we agree is worth nothing if we are arguing about the definition in week five.

SIX

The cost

Deliberately not on this deck. Dan walks the number through live on this call, so you can push on it with the person who built it in the room.

Your list, in your order, with one addition. One channel, the one you told us you stopped running, and the one you said your competition still works.
One, the universe

About 17,000 named decision makers in the roles that buy from you, inside about 24,400 practices.

SegmentPeople on LinkedInPractices with a page
Dermatology20,4005,800
Plastic and cosmetic surgery9,4004,300
Med spa and medical aesthetics8,8005,400
Paraclinic tier*Regenerative, longevity, functional medicine, wellness14,7008,500
Hair restoration and trichology*440300
All five53,70024,400
Of those, in one of the four target rolesOwner or medical director, physician, nurse practitioner, office manager17,000

Med spas are thin on LinkedIn

Of the med spa businesses our own index holds, only about one in four shows a LinkedIn company page at all. That lane gets built on named people, never on company pages.

Hair is small, so it is hand built

The ISHRS 2025 practice census counts 291 physician members in the US and Canada, one read on how concentrated the lane is. No filter builds it properly. A person does.

The paraclinic tier is yours to define

The widest of the five and the loosest. Tell us what the revolving door looks like to you and this lane is rebuilt to your definition, not our keywords.

Your own number is twenty new customers a month in each line. The universe is not the constraint, pace is.
Counted September 10, 2026 across our own data estate and licensed B2B indexes. Three reads span roughly 22,000 to 70,000 people; the figures above are the middle one. Rows are rounded so columns do not sum exactly, and none of this has been through your exclusions or against your own file. *Our keyword reading, and they move once you define them.
Two, the profiles we run from

Three ways to run this. And the one you named that we would not.

OPTION A

Your own profile

Very quiet, by your own description. So it warms rather than leads: the headline, the banner and the about section rebuilt in words your sign-off owner approves, then light activity while other accounts open conversations.

A practice owner who checks you finds a working company, not a dormant page.

OPTION B

A team member's

Your inside sales lead, your marketing lead, or a 1099 rep who wants the warm leads. A real person at Exocel Bio, working their own territory.

They see every message before it goes and every reply as it lands. It stays their account.

OPTION C

Accounts we provide

Real named people on our team, presented as Exocel Bio representatives, set up properly before anything sends: photo, headline, about section, a history of activity.

Each one states its working relationship with Exocel Bio in wording your named owner approves, runs only inside your approved claim set, and stops on the same rules as your own accounts.

Our recommendation for the MVP: up to three accounts. Yours warming quietly, two working. Of the four you named, avatars are the one we will not run: a made up person is what gets an account restricted. Your company page already vouches for us, so week one rewrites its headline, about section and banner in your approved words.
Three, the engagement sequence

One person, one message, written from their own practice.

01

The connection note

One or two lines to a named owner, medical director, physician, nurse practitioner or office manager. Written from their profile and their practice. No pitch in it.

02

The first message

Sent only after they accept. This is where the hook you choose goes, in your approved words, with the reason we are writing to that practice in particular.

03

A short follow up series

Three or four messages over a few weeks, each built on something real about that practice. No two people get the same message. It ends, it does not nag.

04

A no stops it

Immediately, permanently, on every channel we run. Paced well inside LinkedIn's limits, in the practice's own time zone. The first two weeks run slower on purpose.

All four are yours, from our first two calls.
The lab tour
The microscope
A call with your Chief Science Officer
Your own line: if yours is more potent, I'll buy your stock
The hook is your decision, not ours. Tell us which of these can be offered in a first message and we build the opening around it, then test one per lane and tell you which one people answer. Every message runs inside the claim set your named owner has approved in writing, every template is signed off before it is used, and any comparative or potency line appears only in your words.
Four, how it activates

Thirty days, week by week.

Week 1

Built, not sent

Lanes cut from the universe. Names checked against the live profile, not a stale record. Your exclusions loaded as a hard block before anything else.

Profiles set up. Your sign-off owner approves the claim set and every template in writing, in week one and every week after it.

Week 2

Live, slowly

Connection notes only, one lane, deliberately under the limit. Nothing scales in week two.

Every reply read by a person on our side the same business day.

Week 3

The second lane opens

Follow ups begin for the people who accepted in week two. The second lane starts its connection notes.

First read on what your market answers, by lane and by role.

Week 4

Full pace, and the read

Both lanes at working pace inside the limits. Conversations handed over as they land, not batched.

A written read at 30 days: what was said, what was asked, which lane and which hook answer.

The conversation lands where your opens already land: the rep whose name is on that territory, with the whole thread, the same day, into whatever your reps work in. Your routing, not ours. Nothing sends outside your approved claim set, and your email campaigns, your Instagram and your reps carry on exactly as they are.
Five, the KPI

A conversation is a named decision maker, replying, with something your rep can use.

What we count

  • A named person at a target practice, in one of the target roles, replies in their own words.
  • The reply is about exovex, their current exosome, their pricing, or a meeting.
  • It reaches the rep on that territory, or your inside sales lead, with the whole thread, the same day.
Our guarantee

On the call we agree a conversations target for the first 30 days. If we miss it, the following month is on us.

Your number

Twenty new customers a month in each of your three lines, or twenty more like your top twenty. Eighty to a hundred accounts that matter today, on your own count. That is your measure, so the target is set against it and not against a reply count.

We report the ladder honestly: conversation, then a call your rep takes, then a first order. We commit to the first. You close the other two, and we never claim them.

The math the target sits on: about 17,000 people in the target roles, two accounts paced inside the limits, slow for the first fortnight, which is roughly 500 to 800 first touches inside the 30 days. An out of office is not a conversation, and a polite no is a stop, honored the moment it arrives.
Six, the cost

The number is walked through live, on this call.

Not on this deck on purpose, so you hear it from the person who built it and can push on any part of it in the room.

What it covers

  • The accounts, set up and warmed, and the writing on every profile.
  • The list build, the name checking, and your exclusions held as a hard block.
  • The writing, the sending and the pacing, one person at a time.
  • A person reading every reply the same business day, and the handoff to your rep.
  • A weekly read, and the written read at 30 days.

How we can structure it

You raised two ways to structure it last Thursday. Dan takes both on live, with the number.

Whatever we agree is written down before week one, with the conversations target beside it. No handshake numbers.

If it works, we scale it

Your words. Here is what each step up actually means.

NOW

The MVP

One channel, up to three accounts, the lanes we agree today, 30 days. The lowest bar that tells you whether your market answers on LinkedIn.

NEXT

More accounts, more lanes

The same machine, wider. More identities as they mature, the remaining segments opened in the order the data says, not the order they were listed.

THEN

Email alongside

The same named people, one to one, from separate sending domains so exocelbio.com is never exposed to outbound. Two doors to the same person, one record, one rep.

THE BUILD

Four months, then you own it

The whole engine across your lanes, wired into the CRM you run, your operator trained while it runs. The lists, the messaging, the data and the wiring are yours at handover.

Every step is a decision you make on evidence from the one before it. Nothing scales because it was written in a plan, and if the MVP says LinkedIn does not answer for exovex, we will tell you that in writing and you stop.
Inside your lines

You approve every line before it sends.

1

Written to the claim set your sign-off owner approves in writing, and nothing outside it. No names, no protocols, no outcomes.

2

B2B only, the way you already sell. Practices, their owners, their medical directors and their clinicians. Never a patient or a consumer.

3

Your positioning in the exact words your sign-off owner gives us. Nothing added, nothing implied, nothing borrowed from a competitor's page.

4

A no is a hard stop, honored the moment it arrives and permanently. Your exclusion list is loaded before the first message is written.

Every point above is a rule in the build, not a line on a slide. Your named owner has the final word on the claim set, on every template and on every profile we run from, and can pause the whole thing in one call.
Proof

US medical companies, in their own words.

"
Enquirer Consulting Group provided the tools to allow us to personalize outreach at scale in a way that simply wasn't possible before.
Paul Smaldone, Sales DirectorInnovative Medical, US medical, orthopedic and DME
"
ECG and Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
Tim RathChief Operating Officer, Innovative Radiology
$10M+
New business sold for clients
3,500+
Qualified conversations generated
100,000+
Decision makers reached for clients
Cumulative figures from live client work and Business Enquirer client features. New business is client-reported. These are results we have achieved for clients, not a projection of yours.
What we need from you

Six things, and week one starts on them.

1

Your archetypes and your lists

The archetypes and the customer journeys you already hold, plus any target or hit list, so the universe starts from yours and ours fills the gaps.

2

The accounts to leave alone

Current accounts, anyone a rep is working right now, anyone who has asked not to be contacted. Loaded as a hard block before week one.

3

Which accounts we run from

Yours, a team member's, or ours. Slide four is the recommendation. This is your call and it decides week one.

4

The lines, and who signs them

What can and cannot be said about exovex in writing, and the named person on your side who approves it.

5

The first message hook

Whether the lab tour, the microscope, a call with your Chief Science Officer, or your own potency line can be offered in a first message. Confirmed by you before a word is written.

6

The rep map, and who runs Zoho

Who is active, how territories are drawn, and how a warm lead reaches the right rep today. Plus who administers Zoho, so the handoff is wired to what you already run.

Anything you cannot give us becomes a question now, not a surprise in week one.
Deliberately not proposed for the MVP: PR, video, a website rebuild, your social, and email. One channel, done properly, then we scale what works.
Enquirer Consulting Group

Everything you asked for is in front of you.

Arrow keys or tap to move. 13 slides.